CompletedNot Applicable

Risk Factors and the Role of Albumin-to-globulin Ratio in Idiopathic Granulomatous Mastitis

Turkey (Türkiye)109 participantsStarted 2022-04-20

Plain-language summary

Albumin-to-globulin ratio (AGR) is an inflammation-based index that has been shown to have a role in many cancers and inflammatory diseases. Idiopathic granulomatous mastitis (IGM) is a rare inflammatory disease of the breast with a high recurrence rate. As a relatively new biomarker for inflammatory diseases, AGR's role in IGM recurrence has never been investigated in the literature. This study primarily investigates the possible risk factors for IGM recurrence and whether AGR can be used as a predictive factor.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The patients with a pathologically confirmed diagnosis of granulomatous mastitis * Patients over the age of 18 * Female patients Exclusion Criteria: * Male patients * Secondary granulomatous mastitis etiologies (tuberculous mastitis and Wegener's granulomatosis) * Patients who do not have enough follow-up information * Patients with missing data

What they're measuring

IGM recurrence

Timeframe: within an average of 3-4 years of follow-up after treatment

Trial details

NCT IDNCT05409586

SponsorSamsun Education and Research Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-05-20

View on ClinicalTrials.gov More Idiopathic Granulomatous Mastitis trials